Precigen - 5 Year Dividend History | PGEN
Historical dividend payout and yield for Precigen (PGEN) since 2019. The current TTM dividend payout for Precigen (PGEN) as of November 19, 2024 is $0.00. The current dividend yield for Precigen as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.233B |
$0.006B |
|
Precigen Inc. is a biopharmaceutical company. It specialise in the development of gene and cell therapies for immuno-oncology, autoimmune disorders and infectious diseases. The company's transformative therapeutic platforms, including UltraCAR-T(TM), AdenoVerse(TM) cytokine therapies, multifunctional therapeutics and off-the-shelf AdenoVerse(TM) immunotherapies, as well as ActoBio Therapeutics, Exemplar Genetics and Triple-Gene from our subsidiaries. Precigen Inc., formerly known as Intrexon Corporation, is based in Germantown, Maryland.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
